ArticleJournal of drug targeting2021

Delivery of toll-like receptor agonists by complement C3-targeted liposomes activates immune cells and reduces tumour growth.

Alexandra Francian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.